No headlines found.
Globe Newswire (Mon, 8-Dec 8:30 AM ET)
Globe Newswire (Thu, 6-Nov 8:30 AM ET)
SS Innovations Reports Third Quarter 2025 Financial Results
Globe Newswire (Tue, 28-Oct 4:30 PM ET)
SS Innovations to Participate in Upcoming Investor Conferences
Globe Newswire (Tue, 21-Oct 8:30 AM ET)
SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System
Globe Newswire (Thu, 2-Oct 8:30 AM ET)
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
SS Innovations International trades on the NASDAQ stock market under the symbol SSII.
As of December 26, 2025, SSII stock price declined to $5.74 with 91,524 million shares trading.
SSII has a beta of 1.06, meaning it tends to be more sensitive to market movements. SSII has a correlation of 0.01 to the broad based SPY ETF.
SSII has a market cap of $1.11 billion. This is considered a Small Cap stock.
The top ETF exchange traded funds that SSII belongs to (by Net Assets): ISMD, EWX, GINN.
SSII support price is $5.67 and resistance is $6.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SSII shares will trade within this expected range on the day.